Actively Recruiting
In Vivo Liquid Biopsy of Melanoma (Cytophone)
Led by Cytoastra · Updated on 2025-03-11
180
Participants Needed
1
Research Sites
59 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Cytophone is a first in the world patented system to identify and count single circulating melanoma cells in blood circulation inside the human body. The Cytophone has a unique capability to find rare melanoma cells in the blood by an assessment of 100-500 times greater amounts of blood volume than routine blood tests. The important benefit of the Cytophone diagnosis is that the test does not require injection or any skin incision (i.e., non-invasiveness). The goal of this clinical trial is to demonstrate evidence of the capability of the Cytophone test to indicate a risk of metastasis and define CTC counts that correlate with melanoma recurrence, progression of metastatic disease, and therapy efficacy. The investigators believe that clinical trials will provide evidence that the Cytophone can diagnose risk of melanoma metastasis and recurrence earlier than existing methods.
CONDITIONS
Official Title
In Vivo Liquid Biopsy of Melanoma (Cytophone)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histological documented diagnosis of melanoma
- Provided informed consent with signature after full discussion of study requirements and risks
- Able to sit for up to 60 minutes
You will not qualify if you...
- Unable to provide informed consent due to mental condition
- Significant cardiovascular, hepatic, neurological, endocrine, or major systemic disease affecting study participation or safety
- Persistent significant or severe infection, acute or chronic
- Pregnant or breastfeeding women or planning pregnancy during the study
- Women of childbearing potential not using effective contraception or unwilling/unable to undergo pregnancy testing
- Known history of severe preexisting constipation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
SSM Health Dean Medical Group Specialty Services
Madison, Wisconsin, United States, 53715
Actively Recruiting
Research Team
J
James Golleher, MBA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here